BMCM
CVS icon

Bryn Mawr Capital Management’s CVS Health CVS Stock Holding History

Bryn Mawr Capital Management’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$494K Sell
4,778
-225
-4% -$20.1K 0.02% 294
2026
Q1 		$359K Buy
5,003
+1,136
+29% +$87.5K 0.02% 328
2025
Q4 		$307K Buy
3,867
+339
+10% +$26.7K 0.01% 348
2025
Q3 		$266K Buy
+3,528
New +$242K 0.01% 363
2024
Q2 		– Sell
-20,236
Closed -$1.69M – 394
2024
Q1 		$1.69M Sell
20,236
-3,937
-16% -$301K 0.1% 169
2023
Q4 		$1.91M Sell
24,173
-19,040
-44% -$1.36M 0.12% 151
2023
Q3 		$3.02M Buy
43,213
+18,385
+74% +$1.3M 0.2% 107
2023
Q2 		$1.72M Sell
24,828
-894
-3% -$63.6K 0.16% 127
2023
Q1 		$1.91M Sell
25,722
-668
-3% -$56K 0.2% 116
2022
Q4 		$2.46M Sell
26,390
-286
-1% -$27.6K 0.27% 89
2022
Q3 		$2.54M Sell
26,676
-212
-0.8% -$21K 0.9% 19
2022
Q2 		$2.49M Sell
26,888
-507
-2% -$49.5K 0.82% 26
2022
Q1 		$2.77M Buy
27,395
+25,096
+1,092% +$2.64M 0.77% 23
2021
Q4 		$237K Buy
+2,299
New +$212K 0.09% 95
2018
Q1 		– Sell
-2,516
Closed -$205K – 88
2017
Q4 		$205K Hold
2,516
– – 0.27% 57
2017
Q3 		$205K Sell
2,516
-32
-1% -$2.53K 0.21% 69
2017
Q2 		$205K Hold
2,548
– – 0.23% 61
2017
Q1 		$200K Sell
2,548
-98
-4% -$7.82K 0.21% 80
2016
Q4 		$209K Buy
+2,646
New +$214K 0.21% 71

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Bryn Mawr Capital Management's CVS Position: Q2 2026 in Review

Bryn Mawr Capital Management reduced its CVS Health (CVS) stake by 4.5% in Q2 2026, selling an estimated $20.1K and leaving 4,778 shares worth $494K. The position accounts for 0.02% of the portfolio, ranked #294.

Bryn Mawr Capital Management first reported a position in CVS in Q4 2016 and has held it in 19 quarters since. The position peaked at $3.02M in Q3 2023. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Bryn Mawr Capital Management held 4,778 shares of CVS Health worth $494K as of Q2 2026.
  • Bryn Mawr Capital Management sold 225 CVS Health shares in Q2 2026, an estimated $20.1K.
  • CVS Health made up 0.02% of Bryn Mawr Capital Management's portfolio in Q2 2026, its #294 holding.
  • Bryn Mawr Capital Management first reported a position in CVS Health in Q4 2016 and has held it in 19 quarters since.
  • Bryn Mawr Capital Management's CVS Health position peaked at $3.02M in Q3 2023.
  • 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Bryn Mawr Capital Management's 13F filing for Q2 2026, filed 3 Aug 2026.